Correlation Between SurModics and Bone Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SurModics and Bone Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SurModics and Bone Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SurModics and Bone Biologics Corp, you can compare the effects of market volatilities on SurModics and Bone Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SurModics with a short position of Bone Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SurModics and Bone Biologics.

Diversification Opportunities for SurModics and Bone Biologics

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between SurModics and Bone is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding SurModics and Bone Biologics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bone Biologics Corp and SurModics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SurModics are associated (or correlated) with Bone Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bone Biologics Corp has no effect on the direction of SurModics i.e., SurModics and Bone Biologics go up and down completely randomly.

Pair Corralation between SurModics and Bone Biologics

Given the investment horizon of 90 days SurModics is expected to generate 13.19 times less return on investment than Bone Biologics. But when comparing it to its historical volatility, SurModics is 6.69 times less risky than Bone Biologics. It trades about 0.07 of its potential returns per unit of risk. Bone Biologics Corp is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  48.00  in Bone Biologics Corp on August 31, 2024 and sell it today you would earn a total of  2,732  from holding Bone Biologics Corp or generate 5691.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

SurModics  vs.  Bone Biologics Corp

 Performance 
       Timeline  
SurModics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in SurModics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong fundamental indicators, SurModics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Bone Biologics Corp 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, Bone Biologics showed solid returns over the last few months and may actually be approaching a breakup point.

SurModics and Bone Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SurModics and Bone Biologics

The main advantage of trading using opposite SurModics and Bone Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SurModics position performs unexpectedly, Bone Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bone Biologics will offset losses from the drop in Bone Biologics' long position.
The idea behind SurModics and Bone Biologics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk